Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDG-PET/CT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06359054
What this trial is testing

The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging

Who this might be right for
Breast Cancer
Manisa Celal Bayar University 16
Not applicableStudy completedNCT01542541
What this trial is testing

A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans

Who this might be right for
Intestinal FDG Uptake
Beth Israel Deaconess Medical Center 68
Not applicableUnknownNCT06186427
What this trial is testing

A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors

Who this might be right for
CancerMalignant NeoplasmTumors+1 more
Guangdong Provincial People's Hospital 30
Not applicableLooking for participantsNCT07479095
What this trial is testing

Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma

Who this might be right for
Lepidic-Predominant Lung AdenocarcinomaLung Adenocarcinoma
Fondazione del Piemonte per l'Oncologia 30
Not applicableUnknownNCT04514822
What this trial is testing

Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaPositron Emission Tomography
Fifth Affiliated Hospital, Sun Yat-Sen University 40
Testing effectiveness (Phase 2)Study completedNCT00633022
What this trial is testing

Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging

Who this might be right for
Atherosclerosis
GlaxoSmithKline 99
Not applicableStudy completedNCT01916005
What this trial is testing

Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis

Who this might be right for
Prosthetic Valve Endocarditis (PVE)
Assistance Publique Hopitaux De Marseille 174
Not applicableNot Yet RecruitingNCT07127627
What this trial is testing

Characterization of Abdomino-pelvic Lesions by 18Fluorine- Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Who this might be right for
Abdominal Sepsis
Assiut University 79
Not applicableLooking for participantsNCT03888950
What this trial is testing

Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy

Who this might be right for
Metastatic Melanoma
Centre Hospitalier Universitaire de Nice 20
Post-approval studies (Phase 4)Active Not RecruitingNCT04327817
What this trial is testing

Multifidus PET Scan Study

Who this might be right for
Low Back Pain
Barts & The London NHS Trust 20
Not applicableLooking for participantsNCT06199713
What this trial is testing

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

Who this might be right for
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
University of Wisconsin, Madison 24
Not applicableWithdrawnNCT02899325
What this trial is testing

FDGal PET/CT to Detect Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Liver Disease
British Columbia Cancer Agency
Testing effectiveness (Phase 2)Active Not RecruitingNCT05255159
What this trial is testing

Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
University of Alberta 50
Not applicableUnknownNCT03051568
What this trial is testing

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Peking University Cancer Hospital & Institute 80
Not applicableUnknownNCT02969278
What this trial is testing

Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy

Who this might be right for
Vulvar Cancer
Catholic University of the Sacred Heart 50
Very early researchStudy completedNCT00689416
What this trial is testing

Effects of Crestor on Inflammation of Atherosclerotic Plaques

Who this might be right for
AtherosclerosisInflammatory Activity in Carotid Arteries
AstraZeneca 74
Not applicableStudy completedNCT06555861
What this trial is testing

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)

Who this might be right for
Identify FDG PET/CT Parameters Predictive of Local Control
University Hospital, Brest 87
Not applicableEnded earlyNCT03219073
What this trial is testing

Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeuropathic Pain
Thorsten Rudroff 1
Not applicableStudy completedNCT05604482
What this trial is testing

CXCR4-PET/CT for Diagnosing Giant Cell Arteritis

Who this might be right for
VasculitisDiagnoses Disease
Matthias Fröhlich 10
Not applicableUnknownNCT04128631
What this trial is testing

Thyroid Cancer and (FDG)PET/CT Scan

Who this might be right for
Thyroid Cancer
Assiut University 35
Next Page